Review: taking Metoprolol tartrate and Simvastatin together


Summary

Drug interactions are reported among people who take Metoprolol tartrate and Simvastatin together. This review analyzes the effectiveness and drug interactions between Metoprolol tartrate and Simvastatin. It is created by eHealthMe based on reports of 15,440 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 46,723 users)

Simvastatin

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. (latest outcomes from Simvastatin 131,416 users)

On Sep, 17, 2016

15,440 people who take Metoprolol Tartrate, Simvastatin are studied.


Number of reports submitted per year:

Metoprolol tartrate and Simvastatin drug interactions.

Drug effectiveness over time:

Metoprolol Tartrate:
  • < 1 month: 8.0% - (1 of 12 people)
  • 1 - 6 months: 33.0% - (10 of 30 people)
  • 6 - 12 months: 37.0% - (9 of 24 people)
  • 1 - 2 years: 42.0% - (21 of 50 people)
  • 2 - 5 years: 46.0% - (31 of 67 people)
  • 5 - 10 years: 51.0% - (19 of 37 people)
  • 10+ years: 56.0% - (13 of 23 people)
  • not specified: 50.0% - (2 of 4 people)
Simvastatin:
  • < 1 month: 8.0% - (1 of 12 people)
  • 1 - 6 months: 26.0% - (7 of 26 people)
  • 6 - 12 months: 37.0% - (10 of 27 people)
  • 1 - 2 years: 42.0% - (14 of 33 people)
  • 2 - 5 years: 50.0% - (34 of 68 people)
  • 5 - 10 years: 57.0% - (24 of 42 people)
  • 10+ years: 63.0% - (14 of 22 people)
  • not specified: 25.0% - (1 of 4 people)

Drug effectiveness by gender:

Metoprolol Tartrate:
  • female: 45.0% - (41 of 90 people)
  • male: 41.0% - (65 of 157 people)
Simvastatin:
  • female: 50.0% - (43 of 86 people)
  • male: 41.0% - (62 of 148 people)

Drug effectiveness by age:

Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 66.0% - (10 of 15 people)
  • 40-49: 35.0% - (7 of 20 people)
  • 50-59: 44.0% - (25 of 56 people)
  • 60+: 40.0% - (63 of 155 people)
Simvastatin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (7 of 14 people)
  • 40-49: 29.0% - (5 of 17 people)
  • 50-59: 57.0% - (31 of 54 people)
  • 60+: 41.0% - (62 of 149 people)

Most common drug interactions over time *:

< 1 month:
  • pneumonia
  • cardiac arrest
  • renal failure
  • hypotension
  • myalgia
  • rhabdomyolysis
  • asthenia
  • pain
  • dyspnoea
  • renal failure acute
1 - 6 months:
  • abortion missed
  • rhabdomyolysis
  • nausea
  • myalgia
  • acute myocardial infarction
  • cardiac failure congestive
  • dizziness
  • fatigue
  • arthralgia
  • back pain
6 - 12 months:
  • anxiety
  • pain
  • headache
  • asthenia
  • nausea
  • insomnia
  • renal failure
  • skin ulcer
  • blood glucose increased
  • dizziness
1 - 2 years:
  • rhabdomyolysis
  • myocardial infarction
  • dizziness
  • dehydration
  • fatigue
  • dyspnoea
  • anaemia
  • anxiety
  • asthenia
  • chest pain
2 - 5 years:
  • dizziness
  • rhabdomyolysis
  • myocardial infarction
  • myalgia
  • anxiety
  • blood pressure increased
  • headache
  • nausea
  • palpitations
  • pneumonia
5 - 10 years:
  • atrial fibrillation/flutter
  • central sleep apnea
  • myocardial infarction
  • rectal haemorrhage
  • gastrointestinal haemorrhage
  • atrial fibrillation
  • dyspnoea
  • renal failure
  • high blood pressure
  • renal failure acute
10+ years:
  • pneumonia
  • coma
  • diabetic ketoacidosis
  • multi-organ disorder
  • acute myocardial infarction
  • escherichia sepsis
  • myocardial infarction
  • dehydration
  • hepatic cirrhosis
  • atrial fibrillation
not specified:
  • dyspnoea
  • pain
  • nausea
  • fatigue
  • myocardial infarction
  • dizziness
  • asthenia
  • anaemia
  • chest pain
  • anxiety

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • dyspnoea
  • fatigue
  • asthenia
  • dizziness
  • fall
  • myocardial infarction
  • anaemia
  • diarrhoea
male:
  • dyspnoea
  • pain
  • myocardial infarction
  • fatigue
  • nausea
  • dizziness
  • anxiety
  • asthenia
  • cardiac failure congestive
  • chest pain

Most common drug interactions by age *:

0-1:
  • drug ineffective
  • viral infection
2-9:
  • accidental exposure
10-19:
  • cataract
  • cerebral haemorrhage
  • dysuria
  • fall
  • head injury
  • prostatic disorder
  • type 2 diabetes mellitus
  • urinary tract infection
  • urosepsis
  • visual acuity reduced
20-29:
  • asthenia
  • dehydration
  • nausea
  • pain
  • abdominal pain
  • chest pain
  • dizziness
  • dyspnoea
  • hypotension
  • nephrogenic systemic fibrosis
30-39:
  • myocardial infarction
  • hypertension
  • chest pain
  • pain
  • fatigue
  • nausea
  • blood cholesterol increased
  • coronary artery disease
  • gastrooesophageal reflux disease
  • dizziness
40-49:
  • pain
  • anxiety
  • nausea
  • myocardial infarction
  • fatigue
  • chest pain
  • depression
  • dyspnoea
  • injury
  • dizziness
50-59:
  • myocardial infarction
  • pain
  • dyspnoea
  • nausea
  • anxiety
  • chest pain
  • fatigue
  • cardiac failure congestive
  • diarrhoea
  • back pain
60+:
  • dyspnoea
  • pain
  • fatigue
  • nausea
  • dizziness
  • asthenia
  • myocardial infarction
  • anaemia
  • atrial fibrillation
  • fall

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol tartrate and Simvastatin?

Can you answer these questions?

More questions for: Metoprolol tartrate, Simvastatin

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Simvastatin

On eHealthMe, Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Simvastatin (simvastatin) is often used to treat high blood cholesterol. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.